Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Bioanalytical Systems Q1 EPS $(0.03) Beats $(0.19) Estimate, Sales $17.90M Beat $15.33M Estimate

Author: Benzinga Newsdesk | February 09, 2021 05:12pm

Bioanalytical Systems (NASDAQ:BASI) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.19) by 84.21 percent. This is a 57.14 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $17.90 million which beat the analyst consensus estimate of $15.33 million by 16.76 percent. This is a 38.57 percent increase over sales of $12.92 million the same period last year.

Posted In: BASI